Report cover image

In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029

Publisher Kalorama Information
Published Nov 26, 2024
Length 210 Pages
SKU # KLI19343379

Description

In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029


The U.S. IVD market is a cornerstone of global healthcare innovation—but it is also a market in transition In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, the fifth edition in Kalorama’s ongoing series, offers unparalleled access to insights on the trends and technologies that will define the industry's future.

This report is essential for:

Identifying market gaps and opportunities for product innovation.
  • Gaining a competitive edge with strategic insights into the U.S. diagnostic landscape.
  • Making informed decisions by understanding market dynamics and future potential.
  • Staying updated on how evolving regulations are shaping the IVD market.
The U.S. in vitro diagnostics (IVD) market remains the largest and most influential in the world This multi-billion-dollar industry serves as the incubator for cutting-edge medical technologies, driving innovation and setting the benchmark for diagnostic standards worldwide. Yet, this dynamic market faces a period of transformation, balancing challenges such as cost pressures, regulatory changes, and the lingering impacts of COVID-19—all while adapting to a rapidly aging population and increasing demand for precision diagnostics.

Kalorama Information's latest report, In Vitro Diagnostics (IVD) in the United States: Comprehensive Market Overview 2024-2029, delivers a comprehensive analysis of the trends, technologies, and players driving this critical sector. With data-backed insights, this report is your definitive guide to understanding the complexities of the U.S. IVD market.

What’s in the Report
  • Comprehensive Market Analysis: Gain detailed insights into key U.S. IVD segments, including:
  • Clinical Chemistry
  • Microbiology (Traditional) – Identification and Antibiotic Susceptibility Testing (ID/AST)
  • Microbiology – Molecular- Infectious Disease
  • Point-of-Care (POC) Tests – Diabetes
  • Point-of-Care (POC) Tests – All Other
  • Immunoassays – Infectious Disease (non-POC)
  • Immunoassays – Other
  • Molecular - Non-infectious Disease
  • Hematology
  • Coagulation (non-POC)
  • Histology
  • Blood Testing and Typing
  • Others
  • Stay Ahead of the Curve: Understand how demographic shifts, technological advancements, and public health challenges are reshaping the market.
  • Competitive Intelligence: Explore profiles of leading IVD companies, such as Roche Diagnostics, Abbott, Siemens Healthineers, and Thermo Fisher Scientific, and stay informed about their latest developments.
  • Data-Driven Insights: With market data spanning 2024–2029, this report equips readers with the knowledge to identify growth opportunities and make informed decisions.
    • Report Highlights
  • Extensive Market Coverage: Dive deep into U.S. IVD segments, from microbiology and hematology to histology and blood typing.
  • Top Company Profiles: Learn about the strategies and innovations of 20+ key players, including emerging trends and M&A activities.
  • Actionable Insights: Leverage the report's findings to assess the current standard of care, forecast future trends, and anticipate market penetration for new tests and technologies.

Table of Contents

210 Pages
    • U.S. IVD Market
    • Top 12 U.S. IVD Market Participants and Rankings
    • Scope and Methodology
    • Conclusions
    • The United States and In Vitro Diagnostics
    • U.S. Patient Population
    • Clinical Testing under Medicare – Reimbursement Cuts and Market-Based Pricing
    • Personalized Medicine
    • AI Use in U.S. Liquid Biopsy Segment
    • Telehealth
    • Laboratory-Developed Tests (LDTs)
    • U.S. Healthcare Infrastructure and Testing Channels
    • Conclusions
    • Clinical Chemistry
    • Microbiology and Virology – ID/AST and Molecular
    • Point-of-Care Testing
    • Immunoassays
    • Molecular Non-Infectious Disease Diagnostics
    • Coagulation
    • Histology
    • Hematology
    • Blood Testing and Typing
    • Total U.S. IVD Market
    • Top 12 U.S. IVD Competitor Revenues, 2024 ($ million) (Abbott Diagnostics, Becton, Dickinson & Co. [BD], bioMérieux, Danaher Corporation [Beckman Coulter, Leica Biosystems, Radiometer, Cepheid], Dexcom, Exact Sciences, Illumina, Natera, QuidelOrtho, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific)
    • Abbott Diagnostics
    • Becton, Dickinson and Company (BD)
    • bioMérieux
    • Danaher Corporation
    • Dexcom
    • Exact Sciences
    • Hologic, Inc.
    • Illumina
    • Natera
    • QuidelOrtho Corporation
    • Roche Diagnostics
    • Siemens Healthineers (Siemens)
    • Thermo Fisher Scientific Inc.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us